Evaxion Biotech shares are trading higher after the company announced a collaboration with Afrigen Biologics to develop a mRNA vaccine against Gonorrhea.
Portfolio Pulse from Benzinga Newsdesk
Evaxion Biotech has announced a collaboration with Afrigen Biologics to develop a mRNA vaccine against Gonorrhea. This news has led to a rise in Evaxion's stock prices.
September 20, 2023 | 4:05 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Evaxion Biotech's stock prices are trading higher following the announcement of their collaboration with Afrigen Biologics to develop a mRNA vaccine against Gonorrhea.
The announcement of a new collaboration for vaccine development is a positive news for Evaxion Biotech. This could potentially open up new revenue streams for the company, hence the rise in stock prices.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100